Syverson Strege & CO Pfizer Inc Transaction History

Syverson Strege & CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	BUY	$39.39 - $51.28 $393 - $512	10 Added 0.72%	1,402 $57,000
Q4 2022 Feb 06, 2023	BUY	$41.75 - $54.5 $292 - $381	7 Added 0.51%	1,392 $71,000
Q3 2022 Nov 09, 2022	BUY	$43.76 - $53.42 $350 - $427	8 Added 0.58%	1,385 $61,000
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $8,980 - $10,647	-193 Reduced 12.29%	1,377 $72,000
Q1 2022 Apr 13, 2022	BUY	$45.75 - $56.69 $366 - $453	8 Added 0.51%	1,570 $81,000
Q4 2021 Jan 19, 2022	BUY	$41.32 - $61.25 $289 - $428	7 Added 0.45%	1,562 $92,000
Q3 2021 Nov 02, 2021	BUY	$39.25 - $50.42 $274 - $352	7 Added 0.45%	1,555 $67,000
Q2 2021 Aug 04, 2021	BUY	$35.91 - $40.68 $7,505 - $8,502	209 Added 15.61%	1,548 $61,000
Q1 2021 May 07, 2021	BUY	$33.49 - $37.77 $334 - $377	10 Added 0.75%	1,339 $49,000
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $44,481 - $56,562	1,329 New	1,329 $49,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Syverson Strege & CO, based on Form 13F filings with the SEC.

Stay updated on Syverson Strege & CO with notifications on news.